Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1975 Sep;12(3):466–469. doi: 10.1128/iai.12.3.466-469.1975

Binding of cholera toxin by various tissues.

N Gascoyne, W E Van Heyningen
PMCID: PMC415309  PMID: 1165119

Abstract

Under certain conditions, it is possible to confirm the observation by Peterson (1974) that the cholera toxin-binding capacities of tissues from brain and colon mucosa, and from liver and small intestine mucosa, are comparable. Binding of toxin by all tissues except brain is very variable, but is roughtly proportional to their content of the toxin-binding ganglioside galactosyl-N-acetylgalactosaminyl (sialosyl) lactosyl ceramide. It appears that some toxin-binding sites of the mucosa of the small intestin and colon may be masked. It has also been confirmed that there may be some solubilization of toxin-binding material from brain on standing a few days at 4 C, but this is comparatively slight. Some disadvantages of measuring toxin binding by adding small amounts of radioactive toxin to compartively large amounts of tissue are discussed.

Full text

PDF
466

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craig J. P. A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera. Nature. 1965 Aug 7;207(997):614–616. doi: 10.1038/207614a0. [DOI] [PubMed] [Google Scholar]
  2. King C. A., Van Heyningen W. E. Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside. J Infect Dis. 1973 Jun;127(6):639–647. doi: 10.1093/infdis/127.6.639. [DOI] [PubMed] [Google Scholar]
  3. Mellanby J., Pope D., Ambache N. The effect of the treatment of crude tetanus toxin with ganglioside cerebroside complex on sphincter paralysis in the rabbit's eye. J Gen Microbiol. 1968 Mar;50(3):479–486. doi: 10.1099/00221287-50-3-479. [DOI] [PubMed] [Google Scholar]
  4. Penick R. J., Meisler M. H., McCluer R. H. Thin-layer chromatographic studies of human brain gangliosides. Biochim Biophys Acta. 1966 Apr 4;116(2):279–287. doi: 10.1016/0005-2760(66)90010-5. [DOI] [PubMed] [Google Scholar]
  5. Peterson J. W. Tissue-binding properties of the cholera toxin. Infect Immun. 1974 Jul;10(1):157–166. doi: 10.1128/iai.10.1.157-166.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Peterson J. W., Verwey W. F. Radiolabeled toxin for studying binding of cholera toxin and toxoids to intestinal mucosal receptor sites. Proc Soc Exp Biol Med. 1974 Apr;145(4):1187–1191. doi: 10.3181/00379727-145-37978. [DOI] [PubMed] [Google Scholar]
  7. SVENNERHOLM L. Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta. 1957 Jun;24(3):604–611. doi: 10.1016/0006-3002(57)90254-8. [DOI] [PubMed] [Google Scholar]
  8. Van Heyningen W. E., Carpenter C. C., Pierce N. F., Greenough W. B., 3rd Deactivation of cholera toxin by ganglioside. J Infect Dis. 1971 Oct;124(4):415–418. doi: 10.1093/infdis/124.4.415. [DOI] [PubMed] [Google Scholar]
  9. van Heyningen W. E. On the similarity of tetanus and cholera toxins. Naunyn Schmiedebergs Arch Pharmacol. 1973;276(3-4):289–295. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES